Annual EBITDA
-$6.61 M
-$1.17 M-21.44%
March 1, 2024
Summary
- As of February 26, 2025, VRAX annual EBITDA is -$6.61 million, with the most recent change of -$1.17 million (-21.44%) on March 1, 2024.
- During the last 3 years, VRAX annual EBITDA has fallen by -$5.96 million (-925.78%).
- VRAX annual EBITDA is now -925.78% below its all-time high of -$644.30 thousand, reached on March 31, 2021.
Performance
VRAX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VRAX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.4% | - | - |
| 3 y3 years | -925.8% | - | - |
| 5 y5 years | -918.7% | - | - |
VRAX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -925.8% | at low | ||||
| 5 y | 5-year | -925.8% | at low | ||||
| alltime | all time | -925.8% | at low |
Virax Biolabs Group Limited EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | -$6.61 M(+21.4%) | - | - |
| Mar 2023 | -$5.44 M(+213.8%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | -$1.73 M(+169.2%) | - | - |
| Mar 2021 | -$644.30 K(-0.7%) | - | - |
| Mar 2020 | -$648.80 K | - | - |
FAQ
- What is Virax Biolabs Group Limited annual EBITDA?
- What is the all time high annual EBITDA for Virax Biolabs Group Limited?
- What is Virax Biolabs Group Limited annual EBITDA year-on-year change?
What is Virax Biolabs Group Limited annual EBITDA?
The current annual EBITDA of VRAX is -$6.61 M
What is the all time high annual EBITDA for Virax Biolabs Group Limited?
Virax Biolabs Group Limited all-time high annual EBITDA is -$644.30 K
What is Virax Biolabs Group Limited annual EBITDA year-on-year change?
Over the past year, VRAX annual EBITDA has changed by -$1.17 M (-21.44%)